The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.

The ability of IL-2 stimulated mononuclear cells to kill the human glioblastoma cell line U251 has been investigated. Highest cytotoxic activity was generated in low cell density cultures incubated for 15 days with 250-1000 U/ml IL-2. Sub-optimal killing was noted, with cells only exposed to IL-2 fo...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Obukhov, S, Gennie, M, Tutt, A, Kemshead, J, Coakham, H, Beverely, P
Materiálatiipa: Journal article
Giella:English
Almmustuhtton: 1992
_version_ 1826295272161935360
author Obukhov, S
Gennie, M
Tutt, A
Kemshead, J
Coakham, H
Beverely, P
author_facet Obukhov, S
Gennie, M
Tutt, A
Kemshead, J
Coakham, H
Beverely, P
author_sort Obukhov, S
collection OXFORD
description The ability of IL-2 stimulated mononuclear cells to kill the human glioblastoma cell line U251 has been investigated. Highest cytotoxic activity was generated in low cell density cultures incubated for 15 days with 250-1000 U/ml IL-2. Sub-optimal killing was noted, with cells only exposed to IL-2 for three days. Under the latter conditions, bispecific monoclonal antibodies (MoAbs) of either anti-CD3 or anti-CD16 and an anti-NCAM MoAb stimulated LAK cell activity markedly. Anti-CD16 conjugates were found more effective than anti-CD3 and (Fab')2 constructs more efficacious than those made with whole Ig molecules. Maximal stimulation of LAK cell activity was noted with bispecific MoAbs. Little effect was observed with either single or mixtures of monomeric MoAbs. Furthermore, no effect of bispecific MoAbs was observed when target cells lacked expression of NCAM. These results could be of clinical importance as it is not always feasible to screen LAK cells for optimal activity before administration to patients. Whilst bispecific MoAbs have no effect on optimally stimulated LAK cells, they are not inhibitory and can stimulate killing under sub-optimal IL-2 stimulation.
first_indexed 2024-03-07T03:58:28Z
format Journal article
id oxford-uuid:c3b0614c-653c-4c0f-8d15-f092d50ef9df
institution University of Oxford
language English
last_indexed 2024-03-07T03:58:28Z
publishDate 1992
record_format dspace
spelling oxford-uuid:c3b0614c-653c-4c0f-8d15-f092d50ef9df2022-03-27T06:18:18ZThe cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c3b0614c-653c-4c0f-8d15-f092d50ef9dfEnglishSymplectic Elements at Oxford1992Obukhov, SGennie, MTutt, AKemshead, JCoakham, HBeverely, PThe ability of IL-2 stimulated mononuclear cells to kill the human glioblastoma cell line U251 has been investigated. Highest cytotoxic activity was generated in low cell density cultures incubated for 15 days with 250-1000 U/ml IL-2. Sub-optimal killing was noted, with cells only exposed to IL-2 for three days. Under the latter conditions, bispecific monoclonal antibodies (MoAbs) of either anti-CD3 or anti-CD16 and an anti-NCAM MoAb stimulated LAK cell activity markedly. Anti-CD16 conjugates were found more effective than anti-CD3 and (Fab')2 constructs more efficacious than those made with whole Ig molecules. Maximal stimulation of LAK cell activity was noted with bispecific MoAbs. Little effect was observed with either single or mixtures of monomeric MoAbs. Furthermore, no effect of bispecific MoAbs was observed when target cells lacked expression of NCAM. These results could be of clinical importance as it is not always feasible to screen LAK cells for optimal activity before administration to patients. Whilst bispecific MoAbs have no effect on optimally stimulated LAK cells, they are not inhibitory and can stimulate killing under sub-optimal IL-2 stimulation.
spellingShingle Obukhov, S
Gennie, M
Tutt, A
Kemshead, J
Coakham, H
Beverely, P
The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.
title The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.
title_full The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.
title_fullStr The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.
title_full_unstemmed The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.
title_short The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.
title_sort cytotoxic action of lymphokine activated killer cells upon the human glioma cell line u251 is stimulated by bispecific monoclonal antibody moab constructs
work_keys_str_mv AT obukhovs thecytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT genniem thecytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT tutta thecytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT kemsheadj thecytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT coakhamh thecytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT beverelyp thecytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT obukhovs cytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT genniem cytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT tutta cytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT kemsheadj cytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT coakhamh cytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs
AT beverelyp cytotoxicactionoflymphokineactivatedkillercellsuponthehumangliomacelllineu251isstimulatedbybispecificmonoclonalantibodymoabconstructs